SEC Tracker
Get the app
CBIH · XBRL financial data

Cannabis Bioscience International Holdings financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (CBIH's year ends in late May)

In millions of dollarsAug 31, 2011Nov 30, 2011Feb 29, 2012†Nov 30, 2023Feb 29, 2024May 31, 2024Aug 31, 2024Feb 28, 2025May 31, 2025Aug 31, 2025Nov 30, 2025Feb 28, 2026
Revenue———000*000*000
Cost of revenue———000*000*000
Cost of goods and services sold11117—————————
Gross profit652000*0(0)0*000
General and administrative223000*00(0)*000
Total operating expenses———000*000*000
Operating income (loss)53(1)(0)(0)(0)*(0)(0)(0)*(0)(0)(0)
Interest income000—————————
Interest expense000000*000*000
Income tax expense (benefit)110——year only——————
Net income (loss)32(1)(0)(0)(0)*(0)(0)(0)*(0)(0)(0)
Earnings per share, basic USD per share———(0.00)(0.00)0.00*(0.00)(0.00)0.00*(0.00)(0.00)(0.00)
Earnings per share, diluted USD per share———(0.00)(0.00)0.00*(0.00)(0.00)0.00*(0.00)(0.00)(0.00)
Weighted average shares, basic millions of shares———10,33210,37210,235*10,45910,72611,180*11,62711,62711,627
Weighted average shares, diluted millions of shares———10,33210,37210,235*10,45910,72611,180*11,62711,62711,627
  • † Share count changed about 737x in the period ending 2023-11-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal quarters (CBIH's year ends in late May)

In millions of dollarsAug 31, 2011Nov 30, 2011Feb 29, 2012†Nov 30, 2023Feb 29, 2024May 31, 2024Aug 31, 2024Feb 28, 2025May 31, 2025Aug 31, 2025Nov 30, 2025Feb 28, 2026
Cash and cash equivalents000000000000
Accounts receivable434823000000000
Inventory110—————————
Total current assets464925000000000
Property and equipment, net91011—————————
Right-of-use asset———000000000
Total assets106111109000000000
Current portion of long-term debt———000000000
Total current liabilities343635111111111
Long-term debt———000000000
Lease liability, non-current———000000000
Total liabilities353735111111111
Retained earnings (accumulated deficit)182018(5)(5)(5)(5)(6)(6)(6)(6)(6)
Total stockholders' equity677069(1)(1)(1)(1)(1)(1)(1)(1)(1)
Total liabilities and equity106111109000000000
Common shares outstanding (cover page) millions of shares13141410,38210,38210,43210,55710,93211,62711,62711,62711,627
  • † Share count changed about 737x in the period ending 2023-11-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal quarters (CBIH's year ends in late May)

In millions of dollarsAug 31, 2011Nov 30, 2011Feb 29, 2012†Nov 30, 2023Feb 29, 2024May 31, 2024Aug 31, 2024Feb 28, 2025May 31, 2025Aug 31, 2025Nov 30, 2025Feb 28, 2026
Net income (loss)32(1)(0)(0)(0)*(0)(0)(0)*(0)(0)(0)
Stock-based compensation—————year only——————
Net cash from operating activities13*(1)*(0)*(0)*(0)*(0)(0)*(0)*(0)(0)*(0)*
Purchases of property and equipment04*0*—————————
Net cash from investing activities(0)(4)*(0)*—————————
Proceeds from issuing common stock——————0——0——
Proceeds from issuing equity———0*0*(0)*0—0*———
Net cash from financing activities(0)1*1*0*0*0*0—0*———
Net change in cash————0*———————
  • † Share count changed about 737x in the period ending 2023-11-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 8731 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 8731 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingRunwayQuarter
Cannabis Bioscience International Holdings00(0)*11.6B0.0 quarters 10-QFeb 28, 2026
Hypha Labs0not reported(0.1)*163.9M0.1 quarters 10-QJun 30, 2026
iSpecimen4.40.2(0.7)*2.5M6.4 quarters 10-QJun 30, 2026
Foxo Technologies0.14.70.3*1.7M— 10-QJun 30, 2026
Weed00(0)*148.3M0.1 quarters 10-QJun 30, 2026
OneMedNet0.40.3(1.9)*59.3M0.2 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.